Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication February 25, 2020
- Accepted for publication April 22, 2020
- Published online June 4, 2020.
Copyright & Usage
© 2020 by the Society of Nuclear Medicine and Molecular Imaging.
Author Information
- George H. Hinkle, RPh, BCNP
- For correspondence or reprints contact: George H. Hinkle, RPh, BCNP, Radiation Safety Office, Environmental Health and Safety, Ohio State University, 1314 Kinnear Rd., Columbus, OH 43212. E-mail: hinkle.5@osu.edu
Cited By...
Article usage
Jump to section
- Article
- Abstract
- U.S. PHARMACOPEIA (USP)
- THE USP AND RADIOPHARMACEUTICALS
- COMPLIANCE PROBLEMS WITH USP <797> AND RADIOPHARMACEUTICALS AS COMPOUNDED STERILE DRUGS
- USP <825> SCOPE, GOALS, AND OBJECTIVES
- USP <825> RADIOPHARMACEUTICAL-SPECIFIC STANDARDS
- RADIOPHARMACEUTICAL PREPARATION OR COMPOUNDING
- PREPARATION WITH MINOR DEVIATIONS
- RADIOPHARMACEUTICAL PROCESSING ENVIRONMENT
- TRAINING AND QUALIFICATION OF PERSONNEL
- HIGHLIGHTS OF USP <825> FOR NUCLEAR MEDICINE TECHNOLOGISTS
- INTERVENTIONAL AGENTS AND ADJUNCT MEDICATIONS
- FOLLOWING ALARA PRINCIPLES
- THE NUCLEAR MEDICINE HOT LAB
- PREPARATION OF RADIOPHARMACEUTICALS FOR IMMEDIATE USE
- QUALITY CONTROL OF RADIOPHARMACEUTICALS
- RADIOLABELING OF BLOOD COMPONENTS
- PREPARATION OF NONSTERILE RADIOACTIVE PRODUCTS
- BUD ASSIGNMENT
- DIRECT INFUSION SYSTEMS
- USP <825> IMPLEMENTATION TIMELINE
- CONCLUSION
- DISCLOSURE
- Footnotes
- REFERENCES
- Figures & Data
- Info & Metrics